(PEB) Pebblebrook Hotel Trust - Ratings and Ratios
Hotels, Resorts, Properties
PEB EPS (Earnings per Share)
PEB Revenue
Description: PEB Pebblebrook Hotel Trust
Pebblebrook Hotel Trust (NYSE:PEB) is a Hotel & Resort REITs company listed on the New York Stock Exchange. As a Real Estate Investment Trust (REIT), Pebblebrook Hotel Trust is required to distribute at least 90% of its taxable income to shareholders, making it an attractive investment for income-seeking investors.
The companys financial performance is closely tied to the hotel industrys overall health, which is influenced by factors such as occupancy rates, average daily rates (ADR), and revenue per available room (RevPAR). Key economic drivers for Pebblebrook Hotel Trust include GDP growth, tourism demand, and interest rates, which can impact the companys ability to acquire and develop new properties, as well as its borrowing costs.
To evaluate Pebblebrook Hotel Trusts performance, investors can monitor KPIs such as Funds From Operations (FFO) per share, Adjusted Funds From Operations (AFFO) per share, and debt-to-equity ratio. A strong FFO and AFFO growth can indicate a healthy and profitable business, while a manageable debt-to-equity ratio can provide flexibility for future investments and distributions.
The companys quarterly Income Tax Expense is an important aspect of its financial reporting, as it can impact its net income and taxable income. As a REIT, Pebblebrook Hotel Trusts tax obligations are closely tied to its income and distributions, making it essential to monitor its tax expense and ensure compliance with REIT regulations.
PEB Stock Overview
Market Cap in USD | 1,258m |
Sub-Industry | Hotel & Resort REITs |
IPO / Inception | 2009-12-09 |
PEB Stock Ratings
Growth Rating | -44.7% |
Fundamental | 54.7% |
Dividend Rating | 28.2% |
Return 12m vs S&P 500 | -26.6% |
Analyst Rating | 3.0 of 5 |
PEB Dividends
Dividend Yield 12m | 0.35% |
Yield on Cost 5y | 0.32% |
Annual Growth 5y | 0.00% |
Payout Consistency | 91.4% |
Payout Ratio | 126.4% |
PEB Growth Ratios
Growth Correlation 3m | 53.2% |
Growth Correlation 12m | -73.3% |
Growth Correlation 5y | -73.2% |
CAGR 5y | -2.22% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | -1.11 |
Alpha | -35.12 |
Beta | 1.428 |
Volatility | 35.36% |
Current Volume | 2229.8k |
Average Volume 20d | 1722.9k |
Stop Loss | 10.7 (-3.9%) |
Signal | -0.71 |
Piotroski VR‑10 (Strict, 0-10) 4.5
Net Income (-21.7m TTM) > 0 and > 6% of Revenue (6% = 88.2m TTM) |
FCFTA 0.07 (>2.0%) and ΔFCFTA 5.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 14.06% (prev -5.68%; Δ 19.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.05 (>3.0%) and CFO 286.2m > Net Income -21.7m (YES >=105%, WARN >=100%) |
Net Debt (-256.1m) to EBITDA (255.2m) ratio: -1.00 <= 3.0 (WARN <= 3.5) |
Current Ratio 3.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (118.4m) change vs 12m ago -20.94% (target <= -2.0% for YES) |
Gross Margin 20.27% (prev 36.47%; Δ -16.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 25.88% (prev 25.26%; Δ 0.62pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 0.25 (EBITDA TTM 255.2m / Interest Expense TTM 102.0m) >= 6 (WARN >= 3) |
Altman Z'' -1.07
(A) 0.04 = (Total Current Assets 305.8m - Total Current Liabilities 99.1m) / Total Assets 5.65b |
(B) -0.25 = Retained Earnings (Balance) -1.43b / Total Assets 5.65b |
(C) 0.00 = EBIT TTM 25.0m / Avg Total Assets 5.68b |
(D) -0.49 = Book Value of Equity -1.42b / Total Liabilities 2.92b |
Total Rating: -1.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.68
1. Piotroski 4.50pt = -0.50 |
2. FCF Yield 12.70% = 5.0 |
3. FCF Margin 28.19% = 7.05 |
4. Debt/Equity 0.86 = 2.15 |
5. Debt/Ebitda 8.86 = -2.50 |
6. ROIC - WACC 0.47% = 0.58 |
7. RoE -0.81% = -0.14 |
8. Rev. Trend -64.22% = -3.21 |
9. Rev. CAGR -91.95% = -2.50 |
10. EPS Trend -2.51% = -0.06 |
11. EPS CAGR -9.48% = -1.18 |
What is the price of PEB shares?
Over the past week, the price has changed by +4.40%, over one month by +5.69%, over three months by +19.90% and over the past year by -14.14%.
Is Pebblebrook Hotel Trust a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PEB is around 10.40 USD . This means that PEB is currently overvalued and has a potential downside of -6.64%.
Is PEB a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 8
- Sell: 1
- Strong Sell: 2
What are the forecasts/targets for the PEB price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 11.9 | 7% |
Analysts Target Price | 11.9 | 7% |
ValueRay Target Price | 11.9 | 6.6% |
Last update: 2025-08-27 04:45
PEB Fundamental Data Overview
CCE Cash And Equivalents = 256.1m USD (last quarter)
P/E Forward = 24.57
P/S = 0.8559
P/B = 0.4768
P/EG = 0.48
Beta = 1.856
Revenue TTM = 1.47b USD
EBIT TTM = 25.0m USD
EBITDA TTM = 255.2m USD
Long Term Debt = 2.25b USD (from longTermDebt, last quarter)
Short Term Debt = 14.8m USD (from shortTermDebt, last quarter)
Debt = 2.26b USD (Calculated: Short Term 14.8m + Long Term 2.25b)
Net Debt = -256.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.26b USD (1.26b + Debt 2.26b - CCE 256.1m)
Interest Coverage Ratio = 0.25 (Ebit TTM 25.0m / Interest Expense TTM 102.0m)
FCF Yield = 12.70% (FCF TTM 414.4m / Enterprise Value 3.26b)
FCF Margin = 28.19% (FCF TTM 414.4m / Revenue TTM 1.47b)
Net Margin = -1.48% (Net Income TTM -21.7m / Revenue TTM 1.47b)
Gross Margin = 20.27% ((Revenue TTM 1.47b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Tobins Q-Ratio = -2.29 (set to none) (Enterprise Value 3.26b / Book Value Of Equity -1.42b)
Interest Expense / Debt = 1.12% (Interest Expense 25.4m / Debt 2.26b)
Taxrate = -28.83% (set to none) (from quarterly Income Tax Expense: -7.81m / 27.1m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 3.09 (Total Current Assets 305.8m / Total Current Liabilities 99.1m)
Debt / Equity = 0.86 (Debt 2.26b / last Quarter total Stockholder Equity 2.64b)
Debt / EBITDA = 8.86 (Net Debt -256.1m / EBITDA 255.2m)
Debt / FCF = 5.46 (Debt 2.26b / FCF TTM 414.4m)
Total Stockholder Equity = 2.68b (last 4 quarters mean)
RoA = -0.38% (Net Income -21.7m, Total Assets 5.65b )
RoE = -0.81% (Net Income TTM -21.7m / Total Stockholder Equity 2.68b)
RoCE = 0.51% (Ebit 25.0m / (Equity 2.68b + L.T.Debt 2.25b))
RoIC = 0.47% (Ebit 25.0m / (Assets 5.65b - Current Assets 305.8m))
WACC = unknown (E(1.26b)/V(3.52b) * Re(11.28%)) + (D(2.26b)/V(3.52b) * Rd(1.12%) * (1-Tc(none)))
Shares Correlation 5-Years: -100.0 | Cagr: -2.47%
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 70.88% ; FCFE base≈289.6m ; Y1≈343.2m ; Y5≈534.0m
Fair Price DCF = 46.31 (DCF Value 5.49b / Shares Outstanding 118.6m; 5y FCF grow 19.74% → 3.0% )
Revenue Correlation: -64.22 | Revenue CAGR: -91.95%
Rev Growth-of-Growth: 115.1
EPS Correlation: -2.51 | EPS CAGR: -9.48%
EPS Growth-of-Growth: 80.59
Additional Sources for PEB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle